New investigational technology from MicroCHIPS (Lexington, Massachusetts) may make long-term, wireless drug delivery possible. The microchip-based implant is placed under the skin and contains 200 micro-reservoirs that can each store 1 mg of medication. Clinicians can remotely control medication release wirelessly; it can also be outfitted with sensors that release drugs in response to physiologic measures. The first human study of the chip system reported that women receiving teriparitide for osteoporosis absorbed the same therapeutic drug levels as those receiving daily injections. The device also resulted in more dose-to-dose consistency.